[Other] Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trial

 Close Closed
CaterinaC Post time 2024-5-22 18:53:37 | Show all posts |Read mode
Reward10points

PMID: 38750351 / DOI: 10.1038/s41591-024-03003-9
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Junior Member
  • post

  • reply

  • points

    130

Latest Reply

Return to the list